The current three-step manufacturing route for the preparation of tenofovir disoproxil fumarate (1) was assessed and optimized leading to a higher yielding, simpler and greener process. Key improvements in the process route include the refinement of the second stage through the replacement of the problematic magnesium tert-butoxide (MTB) with a 1:1 ratio of a Grignard reagent and tert-butanol. The development of a virtually solvent-free approach and the establishment of a work-up and purification protocol which allows the isolation of a pure diethyl phosphonate ester (8).
Introduction
Tenofovir disoproxil fumarate (1, TDF) and Tenofovir alafenamide fumarate (2, TAF) are pro-drugs of the nucleotide analogue reverse transcriptase inhibitor (NRTI) tenofovir (3, PMPA) developed for the treatment of HIV/AIDS and hepatitis B (figure 1).
1-2 TDF (1) offers several key advantages over other mainstream NRTI's like zidovudine (AZT) and stavudine (d4T) including decreased rates of resistance development, longer half-life and less severe side effects and is currently one of the frontline treatments for the management of HIV/AIDS. 3 TDF (1) is a current frontline drug used for the management of HIV/AIDS, the structurally related TAF (2) is currently undergoing phase 3 clinical trials, it has a greatly reduced dosage relative to that of TDF (1) and is viewed as being a potential future replacement for TDF
(1). TDF (1) and TAF (2) are currently manufactured from commercially available adenine (4) (scheme 1).
The route to TDF involves an alkylation with (R)-4-methyl-1,3-dioxolan-2-one (5, RPA) to afford (R)-9-
[2-(hydroxyl)propyl]adenine (6, HPA). The resulting HPA (6) is then alkylated with tosylated hydroxymethylphosphonate diester (7, DESMP) under basic conditions to afford diethyl phosphonate ester (8, PPA) . The process typically does not facilitate the isolation of pure (8) , instead the material is telescoped directly into stage 3 where hydrolysis of the diethyl phosphonate esters affords PMPA (3).
TDF (1) can then be accessed by alkylative esterification and isolation as the fumaric salt (1).
Alternatively TAF (2) can be accessed in a further three steps from PMPA (3). 4 Despite intensive research efforts, the development of a high yielding process route targeting TDF has to date not been fully realized 6 . This three stage process was originally patented by Gilead affording TDF in a 13 % overall yield, 5 this was more recently improved to 24 % by the Clinton Health Access Initiative (CHAI), who were able to greatly improve stage 3 from 35 % yield based upon PMPA (3) to 62 %. 6 In both instances it was not possible to isolate PPA (8) directly and crude material had to be telescoped to afford PMPA (3). The conversions of stage 2b for the Gilead and CHAI routes at 50 % and 90 % are further compromised by the loss of material in this telescoping process. This report details an improved process route focused in particular on the chemistry, product isolation and purification of stage 2a.
Stage 1
HPA is commonly prepared by reaction of adenine (4) and R-propylene carbonate (5) at 120 °C in the presence of catalytic sodium hydroxide in DMF. The reaction is characterized by the formation of an Scheme 1. Manufacturing route for tenofovir disoproxil fumarate unwanted regioisomer where addition occurs at the exocyclic-NH 2 group, which typically accounts for 7-8 area % of the reaction mixture after completion. 6 Recrystallization from MeOH/iPrOH affords the desired HPA in 97-98 % purity with 1-2 % contamination with the unwanted NH-substituted regioisomer and a total 65 % isolated yield. 6 An assessment was undertaken to investigate the choice of catalyst, solvent, catalyst loading and reaction time on the product yield. The insolubility of adenine in most solvents restricts the solvent choice to high boiling point polar aprotic solvents; DMF, NMP and DMSO and were screened against several catalysts including NaOH, KOH, K 2 CO 3 , (n-Bu) 4 NHOH, LiOH and TsOH. All three solvent choices afforded >90
% conversions when used with NaOH, KOH, K 2 CO 3 and LiOH. n-BuNOH afforded a 95 % conversion in DMSO, but this decreased to 72 % and 55 % when used in NMP and DMF respectively, and TsOH afforded only trace amounts of conversion when performed in DMSO and NMP. Unfortunately product recovery was poor when using DMSO or NMP as solvent. In contrast, when performed in DMF, HPA (6) can be readily precipitated from the reaction mixture.
The choice of catalyst greatly influenced the rate of reaction with K 2 CO 3 >KOH >> NaOH>LiOH (table   1) and when the temperature was increased to 153 °C in the presence of 10 mol% KOH in DMF 95 % conversion was achieved in ~ 30 min (figure 2). Isolation of pure HPA using the CHAI work-up and purification protocol 6 then afforded a 65 % yield of HPA with trace amounts of the unwanted regioisomer. 
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Stage 2a
To date one of the biggest challenges in stage 2 has been the choice of base used to facilitate the coupling of HPA (6) and DESMP (7). Magnesium tert-butoxide (MTB) has been commonly used affording high conversions in excess of 90 %. [6] [7] In reality however the use of MTB is plagued by several factors; it is expensive, the transformation is highly dependent on the quality of the MTB and the magnesium salt byproducts makes the reaction work-up and purification difficult. 6 In particular it is reported that the magnesium salt by-products form a sticky salt cake in which up to 15 % of the PPA (8) formed is lost. 6 The salts are highly hygroscopic, further complicating the telescoping into the stage 2b hydrolysis. The latter is typically performed using moisture sensitive reagents like TMSBr or TMSCl/NaBr. 6, 8 The CHAI approach optimized this method to afford PMPA (3) at a conversion of 90 % but an isolated yield of only 59 % (98.4 % HPLC purity) based upon HPA (6). 6 Several alternative hindered alkoxide bases have been investigated but have only resulted in moderate conversions up to 68 % for stage 2a. 6, 9 The use of strong bases including sodium amide, sodium hydride and di-n-butyl magnesium on their own or in combination with metal salts including magnesium chloride and magnesium acetate followed by hydrolysis have been reported with isolated yields of PMPA (3) in the range of 40-60 %. 10 The use of a Grignard in the form of n-butyl magnesium chloride has also been reported followed by hydrobromic acid hydrolysis affording PMPA (3) in a moderate yield of 47 %. 10 In all cases stage 2a has to be telescoped directly into stage 2b out of necessity due to the difficulties associated with isolating pure PPA (8) from the reaction matrices. [5] [6] 10 Furthermore solvent choices are limited to undesirable high boiling point polar aprotics like DMSO, DMF and NMP, which in addition to being environmentally unfriendly make product isolation difficult.
The CHAI route uses NMP for stage 2 6 whereas the Gilead route and most other approaches use either DMF or DMSO. 5, [7] [8] [9] [10] In order to optimize stage 2 we identified the following needs to find 1) a suitable lower-cost alternative to MTB, 2) a more suitable solvent and 3) the need for an efficient work-up and purification protocol allowing the isolation of pure PPA (8) .
Alternatives to magnesium tert-butoxide
The use of MTB and a range of inorganic and organic bases not previously reported ( The poor results from this initial screen prompted us to look at improving the reactivity by changing the tosyl group of DESMP (7) to a potentially more labile iodo-group. The results were even worse than in the initial screen with only sodium tert-butoxide affording trace amounts of product (entries 5-7 in table 3), and even more surprising was that MTB afford no conversion at all (entries 9 and 10 in table 3) We postulate that the divalent magnesium cation may be coordinating between the phosphonate oxygen and the oxygen(s) in the tosyl group of DESMP (7) to help promote the S N 2 type displacement with HPA (6) (figure 3) this may also explain the observation that MTB works better than the corresponding monovalent sodium, lithium and potassium tert-butoxides.
Figure 3. Proposed reaction of HPA and DESMP with co-ordination of magnesium (II) salts
These results suggested that alternative and more labile leaving groups would be limited to other exotic tosyl derivatives of the hydroxymethylphosphonate diester, and as a consequence we chose to persevere with DESMP (7) which has an established supply chain and rather focus on the optimization of the transformation using Grignard reagents as an alternative to MTB.
As alternative magnesium bases had proved ineffective in affording the transformation (table 2) it was decided to assess if the tert-butoxide groups in MTB were playing an important role by examining the effect of using phenyl magnesium chloride in the presence of tert-butanol. When performed in either DMSO or NMP the reactions showed the formation of both PPA (8) and to our surprise a half-hydrolyzed version of (8) (9, PPA-HH) (figure 4). An HPLC chromatogram shown in figure 5 shows HPA (6) eluting at 1.69 min, followed by PPA-HH (9) and PPA (8) The formation of the half-hydrolyzed product in the absence of water is difficult to explain. We initially thought it may be due to the presence of unaccounted for water in the reaction solvents; however after employing stringent drying conditions to the solvents the phenomenon was still observed. Further thoughts were that there was partial hydrolysis occurring during the preparation of samples for HPLC analysis. This notion was however rejected when it was clearly observed that there was a steady increase in the amount of PPA-HH (9) as reaction time was increased suggesting an underlying reaction path which we were unable to rationalise.
afford PMPA (3) we chose to assess the total conversion of the reaction to be the sum of the area% for both PPA (8) and PPA-HH (9) (table 4) Beyond 2M the solubility of HPA became a limiting factor. Assessment of the choice of Grignard reagent (table 6) showed that the reagent derived from chlorides afforded significantly better conversions than those derived from bromides with phenyl magnesium chloride and methyl magnesium chloride giving the highest conversions (62 % and 57 % respectively).
The conversion dropped off significantly when using a bulky Grignard like 2,2,6,6-tetramethylpiperidinylmagnesium chloride. We decided to focus the process optimisation using methyl magnesium chloride even though phenyl magnesium chloride afforded slightly better conversions as the methyl analogue was more atom-economical, cheaper to source and the reaction was marginally cleaner. The process was further optimized in terms of reaction time; the reaction was monitored by LCMS every fifteen to twenty min for three hours (figure 6). At 75 °C the formation of PPA (8) 
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In an attempt to optimize the stoichiometric amounts of the various reagents and to improve the overall conversion it was decided to investigate the effects of changing the amount of DESMP (7), tert-butanol and methyl magnesium chloride relative to HPA.
In order to assess the effect of tert-butanol we screened the reaction using 0.5 to 2.5 equivalents of tertbutanol ( figure 7) . The results indicated that below 1 equivalent the overall conversion was low (< 40 %), peaking at 78 % for 1 equivalent of tert-butanol, and then steadily decreasing as the amount of tertbutanol was further increased. 
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Encouraged by the dramatic impact that the tert-butanol had on the reaction a number of alternative primary and secondary alcohols (figure 8) were screened. However tert-butanol was found to be the optimal choice with a conversion of 67 %; the other alcohols screened ranged from 13-43 %. 
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PPA-HH (9) PPA ( The amount of DESMP used was screened in the range of 1.5-3.0 equivalents relative to HPA while maintaining the amount of tert-butanol at 1 equivalent. The results showed that conversion reached a maximum of (85-86 %) between 2.3 and 2.6 equivalents ( figure 9) . As a result, standard conditions were adopted to include the use 2.5 equivalents of DESMP (7). Under these conditions the amount of halfhydrolysed PPA (PPA-HH, 9) only represented 1.5-2.3 % of the total conversion. The initial Grignard screen indicated a reduction in conversion as the amount of Grignard increases with 1 equivalent relative to HPA (6) affording the highest conversion. An examination of the effect of using less than 1 equivalent of the Grignard revealed that conversion drops off dramatically with 0.75 equivalents affording 58 % conversion and 0.5 equivalents 38 % conversion. 
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Having optimized the reaction in terms of time, stoichiometry of the various components relative to HPA (6) and choice of base and additives, the effect of changing the order of some of the process steps was studied. The standard procedure involved the preparation of a suspension of HPA (6) and tert-butanol in NMP, to which was added methyl magnesium chloride drop-wise, followed within 30 min by the dropwise addition of DESMP (7). We observed that if the DESMP (7) was introduced prior to the addition of the methyl magnesium chloride the process showed a slight drop in conversion from 86 % to 80 %, and if the methyl magnesium chloride and the tert-butanol are pre-mixed prior to the addition to the HPA and DESMP (7) the conversion drops to 77 %.
Solvent alternatives
A goal of this research was to reduce the need for undesirable solvents. Unfortunately the insolubility of HPA severely limits the choice of solvents to that of high boiling point aprotic polar solvents like DMF, NMP and DMSO.
As the optimized process makes use of excess DESMP which itself is a liquid at ambient temperature, it was proposed that we could forgo the use of NMP and perform the reaction under solvent-free conditions.
A typical approach was to suspend HPA and tert-butanol in DESMP followed by the drop-wise addition of methyl magnesium chloride at 0 °C, thereafter heating the reaction to 75 °C. Under these conditions a 77 % conversion is observed. Unfortunately under the solvent-free conditions the reaction mixture becomes increasingly viscous over time eventually forming a thick, sticky residue which is difficult to stir and process, although at larger scale this problem could potentially be easily handled using an extruder or similar technique. To reduce the viscosity of the reaction we investigated the addition of a small quantity of a low-boiling point solvent that could easily be removed in vacuo after the reaction. Twelve solvents, five polar aprotic, two polar and five non-polar were screened (figure 10).The use of non-polar solvents afforded the highest conversions, the best being cyclohexane with a conversion of 85 %. The co-solvent screen included the use of several solvents that are not compatible with Grignard's in the traditional sense of a solvent. Ethanol and methanol were investigated as we were interested in their effect as a potential solubilizing system which over time would react with the Grignard in an analogous manner to that of tert-butanol to form their respective magnesium bases. Unfortunately in both cases conversion was very poor. More interesting was the use of acetone which was highly efficient at reducing the reaction mixture viscosity. We postulated that it would react with the methyl magnesium chloride to form the tert-butoxide anion, which in turn would form a magnesium base as would have been the case if simply using tert-butanol on its own. As such we viewed acetone as being a green, easy to remove potential substitute for both the tert-butanol and NMP. Unfortunately conversion in the presence of tertBuOH was however poor <20 % and in light of having identified cyclohexane as an excellent co-solvent we abandoned this idea.
The use of cyclohexane as a solvent to reduce reaction mixture viscosity was further screened at 0. (6) PPA (8) than 1 M reaction mixture viscosity made processing difficult. Furthermore the reaction proceeded with better conversion and showed fewer impurities if the tetrahydrofuran and cyclohexane were allowed to slowly boil off approximately 1 h after the addition of the DESMP. 
Reaction work-up and product isolation
The reaction work-up was continuously assessed during the optimizing phase of the project.
Unfortunately in most cases little to no material could be isolated directly out of Stage 2a. Several attempts were made to purify the material including ion-exchange chromatography, recrystallization as a pure material, recrystallization as various salt forms, flash column chromatography and trituration with various solvent systems to no avail. The key issue seemed to be the use of NMP and DMSO as a solvent system both of which are not easily removed and are highly solubilizing of PPA (8) . (7) and an additional unidentified DESMP (7) by-product.
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Basification of the aqueous phase to pH 11 followed by extraction into dichloromethane allows the isolation of pure PPA (8) in a 76 % yield. 12 Re-extraction of the basified aqueous layers under continuous conditions using dichloromethane followed by an acid-base extraction and final extraction into dichloromethane affords a further 9 % recovery of PPA (8) for a total recovery of 85 % with a purity 94-98 % as determined by HPLC.
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Scheme 2: Work-up protocol for the isolation of PPA (8) Chloroform is a potential mutagen and is environmentally unfriendly; as such the use of chloroform is best avoided on scale if possible. Dichloromethane is often used as a replacement for chloroform on scale.
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Unfortunately when we attempted the process by replacing the chloroform in the first extractive process with dichloromethane and running the extraction for the same time (24 h) the overall yield of isolated PPA (8) fell to 55 % after the first continuous extraction. A further 8 % was isolated after the second extraction (63 % total). Interestingly the use of chloroform or dichloromethane in the second extractive process showed no significant difference.
A further examination of the choice of potential extracting solvent was undertaken by assessment of the solubility of PPA (8) in various solvents by dissolving know quantities of PPA (8) Under our conditions the chloroform, dichloromethane extractive process showed the best results. We were able to demonstrate this process on 0.3 mol scale, equating to the use of 58 g of HPA (6) affording a total of 87.6 g of PPA (8) with a purity > 94 %. (8) with a purity > 94 %. 12 The route makes use of low cost reagents to afford the stage 2b transformation, and is certainly more economical than the CHAI and Gilead routes, and competitive with the Laurus route.
All reagents were purchased from Sigma Aldrich with the exception of adenine, RPA, DESMP and MTB which were purchased from Shenzhen Penking Biochemical Technology Co., Ltd.
Analytical analysis was performed on an Agilent 1200 HPLC with a flow-rate of 1 ml/min on a Waters
Xbridge C18 (50 mm x 4.6 mm x 5 microns) coupled to a UV detector (260 nm) and an Agilent 6120
Quadrupole mass spectrophotometer in the positive mode. All purities are reported as HPLC area% results with detection at 260 nm. 1H NMR and 13C NMR data were recorded on a Bruker AVANCE III 400 MHz spectrometer. °C. A mixture of methanol (30 mL) and iso-propanol (30 mL) was added drop-wise to the reaction mixture over 10 min, during which time the reaction mixture was cooled to 55 °C, and precipitation of product was observed. The reaction mixture was cooled to ~ 5 °C and held at this temperature for 1 h. The product was isolated by filtration and the cake was washed with a chilled mixture of methanol (10 mL) and iso-propanol (10 mL). The resulting solid was dried under vacuum at 70-75 °C affording (R)-9-(2-hydroxypropyl)adenine (6) as an off-white solid (37 g, 65 % yield, HPLC purity 98.5 % 
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Preparation of PPA (8).
A mixture of HPA (6, 58 g, 300 mmol) and tert-butanol (28.5 mL, 300 mmol, 1.0 equiv.) was suspended in cyclohexane (300 mL) under argon in a 2L 3-necked round bottom flask fitted with an overhead stirrer. The suspension was charged with methyl magnesium chloride (3M in
Experimental section
THF, 100 ml, 300 mmol, 1.0 equiv.) which was added drop-wise at 0 °C to the rapidly stirring solution.
The reaction mixture was stirred at 0 °C for 30 min before the drop-wise addition of DESMP (7, 193 ml, 750 mmol, 2.5 equiv.). The reaction mixture was heated at 75 °C for 1 h after which time the reaction vessel was opened to boil off the cyclohexane, after 2-3 h HPLC indicated >85 % conversion. The resulting residue was dissolved in water (170 mL) and subjected to continuous extraction with chloroform (2 L) for 24 h. The organic phase was collected, dried (Na 2 SO 4 ), filtered and evaporated in vacuo to afford a yellow oil. HPLC indicated a mixture of HPA (6, 9.7 %), PPA (8, 83.6 %) and DESMP. The oil was taken up in dichloromethane (300 mL) and extracted with 2M HCl (aq) (2 x 150 mL), the organic fraction was collected, dried (Na 2 SO 4 ), filtered and evaporated in vacuo to afford a mixture of unreacted DESMP (7) and the unidentified DESMP (7) by-product. 11 The aqueous phase was basified to pH 11 with 25 % ammonia solution; the basified solution was extracted with dichloromethane (3 x 600 mL). The combined organic phases were dried (Na 2 SO 4 ), filtered and evaporated in vacuo to afford PPA (8) as yellow oil which solidified to a white solid under vacuum (78.3 g, 76 % yield, HPLC purity 94.3 %). The aqueous phase was subjected to continuous extraction with dichloromethane (250 mL), the organic phase was isolated and evaporated in vacuo to afford a clear oil. HPLC indicated a mixture of HPA (6) and PPA (8) . The organic phase was extracted with 2M HCl (aq) (3 x 200 mL), the aqueous phase was basified to pH 11 using 25 % ammonia solution; the basified solution was extracted with dichloromethane (3 x 200 mL). The combined organic phases were dried (Na 2 SO 4 ), filtered and evaporated in vacuo to afford PPA (8) as a yellow oil that solidified to a white solid under vacuum (9.3 g, 9 %, HPLC purity 97 %). The combined batches afforded PPA (8) 
